Search results

1. Development of technology for producing emulsions stabilized using biosurfactants dissolved in the oil phase. Increasing…

Principal investigator: dr hab. Marcel Krzan

Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

Call: OPUS 27, Panel: ST8

2. Three-phase drug carriers - design towards a prolonged release, development of a transport model and its verification. C…

Principal investigator: prof. Anna Trusek

Politechnika Wrocławska

Call: PRELUDIUM BIS 4, Panel: ST8

3. Development of optimization methods for dose selection of analgesic drugs used as a combination drug therapy in neuropat…

Principal investigator: dr hab. Kinga Sałat

Uniwersytet Jagielloński- Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum; Wydział Farmaceutyczny

Call: OPUS 9, Panel: NZ7

4. Search for Inhibitors of Human δ1-Pyrroline-5-Carboxylate Reductase 1 (PYCR1) as Lead Molecules for the Development of N…

Principal investigator: dr hab. Miłosz Ruszkowski

Instytut Chemii Bioorganicznej PAN

Call: OPUS 22, Panel: NZ7

5. Development of new implantable drug forms, biodegradable nanofibers containing selected betulin derivatives in order to …

Principal investigator: prof. Janusz Edward Kasperczyk

Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

Call: OPUS 21, Panel: NZ7

6. DEVELOPMENT OF NEW CLASS PHOTOACTIVATED ANTICANCER-ANTIFUNGAL COMPOUNDS: CONJUGATES OF GOLD NANOPARTICLE-SUPPORTED QUINO…

Principal investigator: dr hab. Oleh M. Demchuk

Katolicki Uniwersytet Lubelski Jana Pawła II, Wydział Medyczny

Call: OPUS 17, Panel: NZ7

7. Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strat…

Principal investigator: dr hab. Robert Czarnomysy

Uniwersytet Medyczny w Białymstoku

Call: OPUS 29, Panel: NZ7

8. Nanospectroscopic imaging of native biological membranes: Is the cell membrane the key for understanding the mechanism o…

Principal investigator: dr Katarzyna Pogoda

Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

Call: SONATA BIS 11, Panel: ST4

9. Dissecting cancer activome to develop new generation of antibody-drug conjugates

Principal investigator: dr hab. Marcin Łukasz Poręba

Politechnika Wrocławska

Call: OPUS 20 (LAP), Panel: NZ5

10. Development of an in vitro model for the evaluation of phototoxicity of drugs with different affinity to melanin using a…

Principal investigator: dr hab. Jakub Rok

Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

Call: SONATA 16, Panel: NZ7

11. Molecular picture of the mechanochemical coupling in ATP synthase as a conceptual framework for the development of novel…

Principal investigator: dr hab. Jacek Czub

Politechnika Gdańska, Wydział Chemiczny

Call: SONATA BIS 7, Panel: NZ2

12. Exosome biosensors - new tools in cancer screening, diagnostics and development of targeted drug delivery system

Principal investigator: dr hab. Magdalena Stobiecka

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

Call: OPUS 13, Panel: ST4

13. Dissecting mechanisms of RNA-based Stress Granules formation, their structure and role in the development of Multi-Drug …

Principal investigator: dr hab. Witold Szaflarski

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

Call: OPUS 9, Panel: NZ7

14. UPLC-MS/MS for methods development for determination of antioxidants and a new generation drugs used in cardiology

Principal investigator: dr Sylwia Magiera

Politechnika Śląska, Wydział Chemiczny

Call: PRELUDIUM 2, Panel: ST4

15. Novel, chemometrically assisted, metabolic based research strategy in anticancer drug development on the example of benz…

Principal investigator: Mariusz Marcin Belka

Gdański Uniwersytet Medyczny, Wydział Faramcautyczny z Oddziałem Medycyny Laboratoryjnej

Call: PRELUDIUM 1, Panel: NZ1

16. Development of novel screening method for identifying xanthine oxidase inhibitors – towards new drug candidates for gout

Principal investigator: dr Monika Katarzyna Rola

Politechnika Łódzka

Call: PRELUDIUM 23, Panel: ST4

17. Deciphering the Chemoproteomics and Chemotranscriptomics of Anti-Alzheimer Drugs for Novel Druggable Target Identificati…

Principal investigator: prof. Krzysztof Sobczak

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

Call: JPND Call 2023, Panel: NZ5

18. Development of bioresorbable polymer materials for the personalized ureteralstents releasing the antispasmodic drug

Principal investigator: prof. Janusz Edward Kasperczyk

Centrum Materiałów Polimerowych i Węglowych PAN

Call: OPUS 25, Panel: ST11

19. Development of methods of isotope-labeled standards preparation for their quantitative analysis by LC-MS in selected dru…

Principal investigator: Paulina Zamiara

Uniwersytet Wrocławski, Wydział Chemii

Call: PRELUDIUM 20, Panel: ST4

20. "Date-rape-drug" pills as a social and analytical challenge - developing a methodology for rapid detection of psychotrop…

Principal investigator: dr hab. Renata Jolanta Wietecha-Posłuszny

Uniwersytet Jagielloński, Wydział Chemii

Call: PRELUDIUM BIS 1, Panel: ST4

21. Isotope labelled ferritin - development of an alternative drug delivery system

Principal investigator: Łukasz Cheda

Uniwersytet Warszawski, Wydział Chemii

Call: PRELUDIUM 18, Panel: ST4

22. Metabolites of Baltic cyanobacteria as natural compound library for high throughput screening and the development of new…

Principal investigator: prof. Hanna Jurata Mazur-Marzec

Uniwersytet Gdański, Wydział Chemii

Call: OPUS 17, Panel: NZ9

23. Tailored lipidic mesophases in drug delivery system developement

Principal investigator: dr Ewa Nazaruk

Uniwersytet Warszawski, Wydział Chemii

Call: SONATA 5, Panel: ST5

24. Molecular mechanism for the effects of stress hormones on development of drug addiction

Principal investigator: prof. Ryszard Przewłocki

Instytut Farmakologii PAN

Call: MAESTRO 4, Panel: NZ3

25. Development of EPR oximetry methodology for evaluation of endothelial action of drugs

Principal investigator: dr Patrycja Kaczara

Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

Call: SONATA 3, Panel: NZ7

26. The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

Principal investigator: dr Michał Jerzy Woźniak

Uniwersytet Medyczny w Łodzi

Call: OPUS 28, Panel: NZ7

27. Development and characterization of novel multitargeted organometallic tubulin polymerization inhibitors for enhancing t…

Principal investigator: dr hab. Damian Nestor Plażuk

Uniwersytet Łódzki

Call: OPUS 27, Panel: NZ7

28. Semaglutide and neurodevelopment: investigating risks arising from prenatal exposure to a widely popular drug for diabet…

Principal investigator: dr hab. Agnieszka Wnuk

Instytut Farmakologii PAN

Call: OPUS 26, Panel: NZ7

29. Design and Development of Serine Hydroxymethyltransferase-2 (SHMT2) Inhibitors Blocking Tumor Growth

Principal investigator: dr hab. Miłosz Ruszkowski

Instytut Chemii Bioorganicznej PAN

Call: SONATA BIS 13, Panel: NZ7

30. New strategies in the pharmacotherapy of neuropathic pain based on modulation of the chemokine system and its influence …

Principal investigator: prof. Joanna Gabriela Mika

Instytut Farmakologii PAN

Call: OPUS 22, Panel: NZ7

31. Development of tools for the rational design of peptide therapeutics

Principal investigator: prof. Sebastian Kmiecik

Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

Call: OPUS 20, Panel: NZ2

32. Development of a comprehensive set of computational tools for the search of new ligands of particular receptor - case st…

Principal investigator: dr hab. Sabina Marta Podlewska

Instytut Farmakologii PAN

Call: OPUS 16, Panel: NZ2

33. Development of protocol for in silico design of compounds inhibit Ebola virus infection

Principal investigator: Dawid Zdzisław Warszycki

Instytut Farmakologii PAN

Call: PRELUDIUM 11, Panel: NZ2

34. Developing of a new system for targeted anticancer therapy based on betulin derivetive and self-organizing polymeric nan…

Principal investigator: prof. Janusz Edward Kasperczyk

Śląski Uniwersytet Medyczny w Katowicach, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej w Sosnowcu

Call: HARMONIA 7, Panel: ST5

35. Development of new strategies for synthesis of inorganic-organic porous materials

Principal investigator: dr Wojciech Bury

Uniwersytet Wrocławski, Wydział Chemii

Call: SONATA BIS 4, Panel: ST5

36. Development of a method for the structure prediction of GPCRs complexes with agonists and antagonists, including the lig…

Principal investigator: dr Michał Koliński

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: SONATA 1, Panel: NZ2

37. A Fungal Hit Discovery Platform

Principal investigator: dr Maria Magdalena Klimecka

Uniwersytet Warszawski

Call: JPIAMR ACTION Call 2024, Panel: NZ1

38. Disruption of the posttranslational activation of the translation factor EF-P as a new target for antimicrobial agents.

Principal investigator: dr Piotr Wilk

Uniwersytet Jagielloński

Call: OPUS 27, Panel: NZ7

39. A Compound Screening Platform for the Discovery of Histone- and Nucleosome-Targeting Agents

Principal investigator: prof. Curtis Davey

Uniwersytet Jagielloński

Call: OPUS 27, Panel: NZ7

Projects search